What percentage of patients with Deep Vein Thrombosis (DVT) develop asymptomatic Pulmonary Embolism (PE)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 23, 2025 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Prevalence of Asymptomatic Pulmonary Embolism in Patients with DVT

Approximately 40-50% of patients with deep vein thrombosis (DVT) have asymptomatic pulmonary embolism (PE). This high prevalence highlights the importance of understanding the relationship between these two manifestations of venous thromboembolism (VTE).

Evidence for Asymptomatic PE in DVT Patients

The European Society of Cardiology (ESC) guidelines provide the most comprehensive data on this topic:

  • When venography is systematically performed in patients with angiographically confirmed PE, a residual DVT is found in approximately 70% of cases 1
  • Conversely, when lung scans are systematically performed in patients with confirmed DVT, approximately 40-50% have evidence of PE despite being asymptomatic 2
  • Perfusion scans show abnormalities in 82% of patients with proximal DVT, with 32-45% having high-probability scans for PE 2

Clinical Significance and Risk Factors

The high prevalence of asymptomatic PE in DVT patients has important clinical implications:

  • PE and DVT are different clinical manifestations of the same disease entity (VTE) 3
  • Autopsy studies have established that PE arises from lower limb DVT in 90% of patients 1
  • The risk of death related to the initial acute episode or recurrent PE is greater in patients who present with PE than in those who present with DVT 3

Diagnostic Considerations

When evaluating patients with DVT, clinicians should be aware that:

  • Compression ultrasonography (CUS) shows a DVT in 30-50% of patients with PE 4
  • Finding a proximal DVT in patients suspected of having PE is considered sufficient to warrant anticoagulant treatment without further testing 4
  • However, patients in whom PE is indirectly confirmed by the presence of a proximal DVT should undergo risk assessment for PE severity and the risk of early death 4

Risk Stratification

Interestingly, the relationship between DVT and PE risk stratification is complex:

  • Patients with high and intermediate risk PE may have a lower incidence of DVT compared to those with low risk PE (67.2% vs 87.8%) 5
  • In PE patients with comorbid DVT, asymptomatic DVT is an independent risk factor for high and intermediate risk PE 5

Clinical Implications

The high prevalence of asymptomatic PE in DVT patients has several important clinical implications:

  • A baseline lung scan may easily detect PE in patients with DVT but is not necessarily useful for predicting early thromboembolic recurrences during therapy 2
  • Despite anticoagulant therapy, VTE recurs frequently in the first few months after the initial event, with a recurrence rate of approximately 7% at 6 months 6
  • Death occurs in approximately 6% of DVT cases and 12% of PE cases within 1 month of diagnosis 6

In conclusion, the high prevalence of asymptomatic PE in patients with DVT (40-50%) underscores the importance of considering these conditions as manifestations of the same disease process and highlights the need for appropriate risk stratification and treatment.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.